Influence of CYP3A5 and ABCB1 Genotypes on Pharmacokinetics of Immediate and Prolonged Release Tacrolimus Preparations

被引:0
|
作者
Elnahhas, T. [1 ,2 ]
Lee, T. [2 ]
Moreton, M. [2 ]
McKeown, D. [2 ]
Popoola, J. [3 ]
Ramkhelawon, R. [3 ]
Johnston, A. [1 ,2 ]
MacPhee, I. [3 ]
机构
[1] Queen Mary Univ London, Dept Clin Pharmacol, London, England
[2] St Georges Univ London, Analyt Serv Int, London, England
[3] St Georges Univ London, Inst Med & Biomed Educ Renal Med, London, England
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
1675
引用
收藏
页数:1
相关论文
共 50 条
  • [1] CYP3A5/ABCB1 Combined Genotype Has Similar Influence On Pharmacokinetics of Immediate and Prolonged Release Tacrolimus in Renal Transplant Recipients
    Elnahhas, T.
    Moreton, M.
    Lee, T.
    McKeown, D.
    Popoola, J.
    Ramkhelawon, R.
    Johnston, A.
    MacPhee, I.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 548 - 548
  • [2] CYP3A5/ABCB1 Combined Genotype Has Similar Influence On Pharmacokinetics of Immediate and Prolonged Release Tacrolimus in Renal Transplant Recipients.
    Elnahhas, T.
    Moreton, M.
    Lee, T.
    McKeown, D.
    Popoola, J.
    Ramkhelawon, R.
    Johnston, A.
    MacPhee, I.
    TRANSPLANTATION, 2014, 98 : 548 - 548
  • [3] Recipient ABCB1, donor and recipient CYP3A5 genotypes influence tacrolimus pharmacokinetics in liver transplant cases
    Shaik Mohammad Naushad
    Addepalli Pavani
    Yedluri Rupasree
    Tajamul Hussain
    Salman A. Alrokayan
    Vijay Kumar Kutala
    Pharmacological Reports, 2019, 71 : 385 - 392
  • [4] Recipient ABCB1, donor and recipient CYP3A5 genotypes influence tacrolimus pharmacokinetics in liver transplant cases
    Naushaed, Shaik Mohammad
    Payani, Addepalli
    Rupasree, Yedluri
    Hussain, Tajamul
    Alrokayan, Salman A.
    Kutala, Vijay Kumar
    PHARMACOLOGICAL REPORTS, 2019, 71 (03) : 385 - 392
  • [5] CYP3A5 and ABCB1 genotype influence tacrolimus and sirolimus pharmacokinetics in renal transplant recipients
    Li, Yi
    Yan, Lin
    Shi, Yunying
    Bai, Yangjuan
    Tang, Jiangtao
    Wang, Lanlan
    SPRINGERPLUS, 2015, 4
  • [6] Time of Drug Administration, CYP3A5 and ABCB1 Genotypes, and Analytical Method Influence Tacrolimus Pharmacokinetics: A Population Pharmacokinetic Study
    Musuamba, Flora Tshinanu
    Mourad, Michel
    Haufroid, Vincent
    Delattre, Isabelle Karine
    Verbeeck, Roger Karel
    Wallemacq, Pierre
    THERAPEUTIC DRUG MONITORING, 2009, 31 (06) : 734 - 742
  • [7] Effect of CYP3A5, CYP3A5 and ABCB1 Genotypes in Tacrolimus Dose and Clinical Outcomes after Heart Transplantation
    Tavira, B.
    Diaz-Molina, B.
    Lambert, J. L.
    Bernardo, M. J.
    Moris, C.
    Alvarez, V.
    Lopez-Larrea, C.
    Coto, E.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2012, 31 (04): : S154 - S154
  • [8] Influence of CYP3A5 and MDR1 (ABCB1) polymorphisms on the pharmacokinetics of tacrolimus in renal transplant recipients
    Tsuchiya, N
    Satoh, S
    Tada, H
    Li, ZH
    Ohyama, C
    Sato, K
    Suzuki, T
    Habuchi, T
    Kato, T
    TRANSPLANTATION, 2004, 78 (08) : 1182 - 1187
  • [9] Flecainide Pharmacokinetics are Influenced by CYP3A5 and ABCB1 Polymorphisms
    Yang, Y. L.
    Hu, M.
    Chan, S. W.
    Fok, B. S. P.
    Chu, T. T. W.
    Lee, V. H. L.
    Tomlinson, B.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2011, 147 : S26 - S26
  • [10] Influence of CYP3A5 and MDR1(ABCB1) Polymorphisms on the Pharmacokinetics of Tacrolimus in Chinese Renal Transplant Recipients
    Rong, G.
    Jing, L.
    Deng-Qing, L.
    Hong-Shan, Z.
    Shai-Hong, Z.
    Xin-Min, N.
    TRANSPLANTATION PROCEEDINGS, 2010, 42 (09) : 3455 - 3458